Phys Vivas · infectious
CNS Infections — Viva Defence
Structured DCE viva for CNS infections: long-case defence of post-pneumococcal meningitis follow-up plus probing questions on sequencing, steroids, and special populations.
On this page & tools
Target exams
Opening statement (SASPOP, delivered aloud)
"Mr Nguyen is a 46-year-old man, three weeks post pneumococcal meningitis complicated by seizures and ICU care, presenting with new hearing difficulty. His main problems are: recovering from a severe CNS infection with neurological sequelae; determining whether an underlying susceptibility exists; secondary prevention through vaccination; and rehabilitation of his hearing. My plan is to complete a complications screen, investigate immune susceptibility, vaccinate, and coordinate his recovery." [1]
Structured problem list
- Post-meningitis neurological sequelae — seizures during the illness (now resolved); new hearing difficulty, which may be sensorineural hearing loss, the signature late complication [1].
- Underlying susceptibility to pneumococcal disease — asplenia, complement deficiency, immunoglobulin deficiency, chronic disease; none yet excluded [3].
- Secondary prevention — vaccination strategy once his course is clear.
- Rehabilitation and return to function — hearing, cognition, driving restrictions after seizures, psychological recovery.
Integrated management plan
- Complications screen: formal audiology for the hearing loss (sensorineural loss after bacterial meningitis is common and permanent management may follow), cognitive screen, and review of his seizure status with driving advice [1].
- Susceptibility workup: immunoglobulins and subclasses, complement pathway studies, HIV test, and assessment for asplenia (film for Howell-Jolly bodies, abdominal ultrasound if suggested) [3].
- Vaccination: pneumococcal (conjugate then polysaccharide per schedule), meningococcal, Hib and influenza — framed around any susceptibility found; if asplenic, add antibiotic standby education.
- Recovery coordination: audiology, neurology follow-up for seizures, staged return to work, and clear documentation of the illness for his GP.
Probing questions with model answers
"Why did you give dexamethasone, and does timing matter?" — "The European trial showed dexamethasone 10 mg four times daily for four days, started with or before the first antibiotic dose, reduced death and unfavourable outcome in community bacterial meningitis — with benefit concentrated in pneumococcal disease, which is exactly his organism. Started late, it is ritual rather than evidence" [2].
"Would you have done a CT before his LP?" — "Only if one of the Hasbun criteria applied: immunocompromise, prior CNS disease, seizure within the week, papilloedema, abnormal consciousness or focal deficit. He seized in the emergency department, so yes — but after cultures, antibiotics and steroids, never before them" [1].
"His brother asks if the family needs antibiotics." — "Pneumococcal meningitis does not require contact chemoprophylaxis — that obligation belongs to meningococcal disease. I would explain that, and use the conversation to reinforce the family's own vaccination where indicated" [3].
"What if this had been meningococcus instead?" — "Then notification and chemoprophylaxis for close contacts — household, kissing, secretion exposure — with ciprofloxacin or rifampicin per local guidance, and I would screen him later for complement deficiency, which classically predisposes to recurrent meningococcal disease" [3].
Communication points
- Explain hearing loss honestly: it may be permanent, and early audiology changes options.
- Answer "why me?" with the susceptibility plan — it converts anxiety into a concrete workup.
- Driving and seizure rules must be explicit in writing at discharge [1].
References
- [1]van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults N Engl J Med, 2006.PMID 16394301
- [2]de Gans J, van de Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis N Engl J Med, 2002.PMID 12432041
- [3]Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis Clin Infect Dis, 2004.PMID 15494903